Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia

Dye, 2001, Worldwide incidence of multidrug‐resistant tuberculosis, J Infect Dis, 185, 1197, 10.1086/339818

Anonymous, 2006, European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance, Emerg Infect Dis, 12, 736

Sreevatsan, 1997, Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination, Proc Natl Acad Sci USA, 94, 9869, 10.1073/pnas.94.18.9869

Ramaswamy, 1998, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: update, Tuberc Lung Dis, 79, 3, 10.1054/tuld.1998.0002

Ramaswamy, 2003, Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 47, 1241, 10.1128/AAC.47.4.1241-1250.2003

Herrera, 2003, Molecular analysis of rifampin‐resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature, Int J Antimicrob Agents, 21, 403, 10.1016/S0924-8579(03)00036-0

Zhang, 2005, Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China, J Clin Microbiol, 43, 5477, 10.1128/JCM.43.11.5477-5482.2005

Kamerbeek, 1997, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, 35, 407, 10.1128/JCM.35.4.907-914.1997

Van Embden, 1993, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology, J Clin Microbiol, 31, 406, 10.1128/JCM.31.2.406-409.1993

Supply, 2000, Variable human minisatellite‐like regions in the Mycobacterium tuberculosis genome, Mol Microbiol, 36, 762, 10.1046/j.1365-2958.2000.01905.x

Filliol, 2002, Global distribution of Mycobacterium tuberculosis spoligotypes, Emerg Infect Dis, 8, 1347, 10.3201/eid0811.020125

Glynn, 2002, Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review, Emerg Infect Dis, 8, 843, 10.3201/eid0805.020002

Mokrousov, 2002, Molecular characterization of multiple‐drug‐resistant Mycobacterium tuberculosis strains from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene, Res Microbiol, 153, 213, 10.1016/S0923-2508(02)01311-6

Shemyakin, 2003, Characterization of Mycobacterium tuberculosis clinical strains by molecular‐biology methods, J Mol Gen Microbiol Virol (Russia), 1, 32

Shemyakin, 2002, Genetic typing of Mycobacterium tuberculosis strains by spoligotyping and genome fingerprinting techniques, J Microbiol Epidemiol Immunol (Russia), 6, 30

Shemyakin, 2004, Characterization of drug‐resistant clinical isolates of Mycobacterium tuberculosis derived from Russian inmates, Int J Tuberc Lung Dis, 8, 1194

Toungoussova, 2002, Spread of drug‐resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia, J Clin Microbiol, 40, 1930, 10.1128/JCM.40.6.1930-1937.2002

Mokrousov, 2002, High prevalence of KatG Ser315Thr substitution among isoniazid‐resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996–2001, Antimicrob Agents Chemother, 46, 1417, 10.1128/AAC.46.5.1417-1424.2002

Canetti, 1969, Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes, Bull WHO, 41, 21

Sanger, 1977, DNA sequencing with chain‐terminating inhibitors, Proc Natl Acad Sci USA, 74, 5463, 10.1073/pnas.74.12.5463

Van Doorn, 2001, The susceptibility of Mycobacterium tuberculosis to isoniazid and the ArgLeu mutation at codon 463 of katG are not associated, J Clin Microbiol, 39, 1591, 10.1128/JCM.39.4.1591-1594.2001

Cohn, 1997, The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries, Int J Tuberc Lung Dis, 2, 16

Wengenack, 1997, Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase‐peroxidase with reduced activity toward isoniazid, J Infect Dis, 176, 722, 10.1086/514096

Valim, 2000, Mutations in the rpoB gene of multidrug‐resistant Mycobacterium tuberculosis strains from Brazil, J Clin Microbiol, 38, 3119, 10.1128/JCM.38.8.3119-3122.2000

Gingeras, 1998, Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays, Genome Res, 8, 435, 10.1101/gr.8.5.435

Siddiqi, 2002, Molecular characterization of multidrug‐resistant strains of Mycobacterium tuberculosis from patients in North India, Antimicrob Agents Chemother, 46, 443, 10.1128/AAC.46.2.443-450.2002

Heep, 2001, Frequency of rpoB mutations inside and outside the cluster I region in rifampin‐resistant Mycobacterium tuberculosis clinical strains, J Clin Microbiol, 39, 107, 10.1128/JCM.39.1.107-110.2001

Yuen, 1999, Bacteriological and molecular analysis of rifampin‐resistant Mycobacterium tuberculosis strains in Australia, J Clin Microbiol, 37, 3844, 10.1128/JCM.37.12.3844-3850.1999

Billington, 1999, Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 43, 1866, 10.1128/AAC.43.8.1866

Musser, 1995, Antimicrobial agent resistance in mycobacteria: molecular genetic insights, Clin Microbiol Rev, 8, 496, 10.1128/CMR.8.4.496

Williams, 1998, Contribution of rpoB mutations to development of rifamycin cross‐resistance in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 42, 1853, 10.1128/AAC.42.7.1853

Mardassi, 2005, Tuberculosis due to resistant Haarlem strain, Tunisia, Emerg Infect Dis, 11, 957, 10.3201/eid1106.041365